Basilea Pharmaceutica International Ltd, Allschwil Contracts with Department of Health and Human Services
Relationship Overview
Total Contract Value: $229,583,546
Contract Count: 3
Average Contract Size: $76.5M
Sole Source Rate: 0%
Small Business Rate: 0%
Spending by Sector
- Other: $229.6M (3 contracts)
Contracts
- IGF::OT::IGF ADVANCED DEVELOPMENT OF CEFTOBIPROLE — $110.6M
- THE DEVELOPMENT OF ANTIMICROBIALS FOR THE TREATMENT OF RESISTANT FUNGAL AND BACTERIAL INFECTIONS - OTA — $92.5M
- VENATORX PHARMACEUTICALS: NEW ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA INCLUDING PUBLIC HEALTH PATHOGENS. — $26.4M
Frequently Asked Questions
How many contracts does Basilea Pharmaceutica International Ltd, Allschwil have with Department of Health and Human Services?
Basilea Pharmaceutica International Ltd, Allschwil has 3 contracts with Department of Health and Human Services worth a combined $229.6M.
What is the average contract size between Basilea Pharmaceutica International Ltd, Allschwil and Department of Health and Human Services?
The average contract size is $76.5M.
What percentage of Basilea Pharmaceutica International Ltd, Allschwil's contracts with Department of Health and Human Services are sole-source?
0% of the contracts are sole-source awards.